This IQVIA MedTech insight brief examines the rapid adoption of Pulsed Field Ablation (PFA), a next-generation treatment for atrial fibrillation. Combining real-world utilization data with physician survey findings, the report explores why PFA is being adopted faster than many previous MedTech innovations. Physicians cite improved safety profiles, shorter procedure times, fewer complications, and better procedural efficiency compared with traditional ablation technologies. The brief also highlights shifting competitive dynamics within the cardiac ablation market, predicts continued growth toward widespread adoption, and demonstrates how combining real-world evidence with rapid physician feedback can provide strategic insights in fast-moving healthcare markets.

Join for free to read